Global Leading Market Research Publisher QYResearch announces the release of its latest report “Herbal Supplement for Mental Health – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Herbal Supplement for Mental Health market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Herbal Supplement for Mental Health was estimated to be worth US8,200millionin2025andisprojectedtoreachUS8,200millionin2025andisprojectedtoreachUS14,500 million by 2032, growing at a CAGR of 8.6% from 2026 to 2032. For health-conscious consumers, mental wellness advocates, and natural product retailers, the core business imperative lies in selecting herbal supplements for mental health that address the critical need for natural, plant-based alternatives to pharmaceutical antidepressants, anxiolytics, and stimulants for managing stress, anxiety, depression, sleep disorders, cognitive decline, memory loss, brain fog, and mood swings, with fewer side effects (no sexual dysfunction, weight gain, insomnia, gastrointestinal disturbance, dependence) compared to prescription medications (selective serotonin reuptake inhibitors (SSRIs), benzodiazepines, stimulants). Key herbal ingredients: St. John’s Wort (Hypericum perforatum) for mild-to-moderate depression; Ginkgo Biloba for cognitive function, memory, dementia, cerebral insufficiency; Rhodiola Rosea for stress, fatigue, burnout, mental performance; Bacopa Monnieri for memory, learning, cognitive enhancement, anxiety; Passionflower (Passiflora incarnata) for anxiety, insomnia, nervous restlessness; Ashwagandha (Withania somnifera) for stress, anxiety, cortisol reduction, brain function; Lemon Balm (Melissa officinalis) for calm, sleep, cognitive performance; Valerian Root (Valeriana officinalis) for sleep, anxiety; Chamomile (Matricaria chamomilla) for mild anxiety, sleep; Gotu Kola (Centella asiatica) for cognitive function, memory, mental fatigue; Saffron (Crocus sativus) for depression, mood, anxiety. Mechanisms: serotonin reuptake inhibition (St. John’s Wort), MAO-B inhibition (Rhodiola, Bacopa), GABA (gamma-aminobutyric acid) modulation (passionflower, valerian, ashwagandha), antioxidant (all), anti-inflammatory, neuroprotection, adaptogenic (stress resistance). Applications: offline sales (specialty health stores, GNC, pharmacies, supermarkets, Whole Foods, Sprouts, Vitamin Shoppe, Boots, Holland & Barrett) and online sales (Amazon, iHerb, brand DTC). Key players: Amway (Nutrilite), Nestlé Health (Nature’s Bounty, Pure Encapsulations), Herbalife Nutrition, Schwabe (Germany– Perika St. John’s Wort), Gaia Herbs, Arkopharma (France), Weleda (Germany/Switzerland), NOW Foods, Jamieson (Canada), Natrol, Blackmores (Australia), Health and Happiness (H&H) SWISSE (China), Jarrow Formulas, Life Extension, Nordic Naturals, Thorne Research, HUM Nutrition, Unilever (Onnit), Moon Juice, Nutrigold.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/releases/5975699/herbal-supplement-for-mental-health
The Herbal Supplement for Mental Health market is segmented as below:
Amway
Nestlé Health (Nature’s Bounty)
Herbalife Nutrition
Schwabe
Gaia Herbs
Arkopharma
Weleda
NOW Foods
Jamieson
Natrol
Blackmores
Health and Happiness (H&H) SWISSE
Jarrow Formulas
Life Extension
Nordic Naturals
Thorne Research
HUM Nutrition
Unilever (Onnit)
Moon Juice
Nutrigold
Segment by Type
St. John’s Wort
Ginkgo Biloba
Rhodiola Rosea
Bacopa Monnieri
Passionflower
Others
Segment by Application
Offline Sales
Online Sales
1. Market Drivers: Mental Health Awareness, Natural Trends, and COVID Stress
Several powerful forces are driving the herbal supplement for mental health market:
Rising mental health awareness (depression, anxiety) – WHO (World Health Organization): 280M depression, 300M anxiety. Post-COVID mental health crisis stress, burnout, isolation.
Consumer preference for natural, plant-based alternatives – Ease side effects (SSRI discontinuation syndrome). “Clean label,” organic, non-GMO.
Adaptogen and nootropic trend – Enhance cognitive function, stress resilience (Rhodiola, Bacopa, Ashwagandha). Social media (TikTok).
Recent market data (December 2025): According to Global Info Research analysis, St. John’s Wort largest segment with approximately 25% revenue share (depression, Europe, US). Ginkgo Biloba 20% share (memory, cognitive, dementia). Rhodiola Rosea 15% share (stress, fatigue). Bacopa Monnieri 10% share (memory, anxiety). Passionflower 8% share. Others (Ashwagandha, Lemon Balm, Valerian, Chamomile) 22% share. Offline sales (retail) dominate with approximately 65% revenue share (in-store consultation, impulse). Online sales 35% share (fastest-growing 12-14% CAGR). North America (US) largest market (40% share). Europe (Germany, UK) 30% share. Asia-Pacific 20% share. Nestlé Health (Nature’s Bounty, Pure Encapsulations), Schwabe, NOW Foods, Gaia Herbs, Blackmores, Swisse leaders.
2. Key Herbal Ingredients and Applications
| Ingredient | Primary Use | Mechanism | Clinical Evidence | Standardization | Form | Share |
|---|---|---|---|---|---|---|
| St. John’s Wort | Mild-moderate depression | SNRI (Serotonin-Norepinephrine Reuptake Inhibitor) | Hypericum depression trial (HYP) (vs SSRI) | Hypericin 0.3% | Capsule, tablet, tea | ~25% |
| Ginkgo Biloba | Memory, cognitive | Antioxidant, cerebral blood flow | EGb 761 (Alzheimer’s) | Flavonoids 24%, terpenes 6% | Capsule, tablet | ~20% |
| Rhodiola Rosea | Stress, fatigue | Adaptogen, MAO-B inhibition | RCT (fatigue) | Rosavin 3%, salidroside 1% | Capsule | ~15% |
| Bacopa Monnieri | Memory, anxiety | Acetylcholine modulation, antioxidant | CDRI-08 | Bacosides 20-50% | Capsule | ~10% |
| Passionflower | Anxiety, insomnia | GABA agonist, MAO inhibition | RCT (anxiety) | Vitexin, isovitexin | Capsule, tincture | ~8% |
Other notable ingredients: Ashwagandha (KSM-66, Sensoril), Lemon Balm, Valerian (sleep), Chamomile, Saffron (affron), Gotu Kola. Evidence: St. John’s Wort inferior to SSRIs for severe depression, not FDA approved (US). Ginkgo not prevent dementia (GEM study). Adaptogens: Rhodiola, ashwagandha acute stress.
Exclusive observation (Global Info Research analysis): Herbal supplement for mental health market is consolidated among large multinational supplement companies (Nestlé Health (Nature’s Bounty, Pure Encapsulations), Amway (Nutrilite), Herbalife, Unilever (Onnit), Blackmores, Swisse) and specialized herbal brands (Schwabe (St. John’s Wort), Gaia Herbs (organic), Weleda (anthroposophic), NOW Foods (value), Jarrow Formulas (methylated), Thorne (premium, practitioner), Life Extension (science). Social media influencers drive adaptogen (ashwagandha, rhodiola) growth. Drug interactions: St. John’s Wort (CYP3A4 inducer) interacts with oral contraceptives, anticoagulants, antidepressants (serotonin syndrome).
User case – mild depression (December 2025): European patient (Germany) self-medicates mild depression with St. John’s Wort extract (Schwabe, Perika, 300mg, 3x daily). No side effects. Improvement in PHQ-9 (Patient Health Questionnaire-9) after 8 weeks.
User case – exam stress (January 2026): University student (Canada) takes Rhodiola Rosea (NOW Foods, 250mg) 30 minutes before exams. Reduces anxiety, improves mental focus (RCT evidence).
3. Technical Challenges
Drug interactions (St. John’s Wort) – Induces CYP (cytochrome P450) enzymes (CYP3A4, CYP2C9, P-glycoprotein). Reduces efficacy of oral contraceptives, warfarin, statins, immunosuppressants.
Standardization and bioavailability (Ginkgo, Bacopa) – Herbal extracts vary (proprietary). Clinical doses differ (EGb 761, CDRI-08). Water soluble low (Bacopa), lipid-soluble (Ginkgo). Enhance absorption (pepperine, liposomal).
Technical difficulty – FDA regulatory limitation: Herbal supplements not approved for mental health claims (disease claim). Labeled “supports mood, cognitive function.” Not treat depression. Disclaimers.
Technical development (October 2025): Nestlé Health (Nature’s Bounty) launched ashwagandha gummy (KSM-66, 300mg) for stress and calm. Improved compliance.
4. Competitive Landscape
Key players include: Amway (US – Nutrilite), Nestlé Health (US – Nature’s Bounty, Pure Encapsulations, Solgar?), Herbalife Nutrition (US), Schwabe (Germany – St. John’s Wort), Gaia Herbs (US – organic), Arkopharma (France), Weleda (Switzerland/Germany), NOW Foods (US), Jamieson (Canada), Natrol (US), Blackmores (Australia), H&H SWISSE (China/Australia), Jarrow Formulas (US), Life Extension (US), Nordic Naturals (US – fish oil, brain health), Thorne Research (US – practitioner), HUM Nutrition (US – DTC), Unilever (Onnit – Alpha BRAIN), Moon Juice (US – adaptogens), Nutrigold (US). Nestlé Health, Schwabe, NOW, Blackmores leaders.
Regional dynamics: North America (Amway, Nestlé, Herbalife, NOW, Gaia, Jarrow, Life Extension, Thorne, HUM, Onnit, Nutrigold) largest. Europe (Schwabe, Arkopharma, Weleda). Asia-Pacific (Blackmores, Swisse). Online sales fastest-growing (Amazon, iHerb, DTC).
5. Outlook
Herbal supplement for mental health market will grow at 8.6% CAGR to US$14.5 billion by 2032, driven by mental health awareness, natural trends, and adaptogen popularity. Technology trends: liposomal delivery, standardized extracts (clinical doses), and gummy format. Online sales growth 12-14% CAGR. Asia-Pacific growth 10-12% CAGR (urban stress). Ashwagandha, rhodiola, saffron fastest-growing.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
